Home / Inspections / 741722

FDA Inspection 741722 — McGuff Pharmaceuticals, Inc.

McGuff Pharmaceuticals, Inc. — FEI 2022073

The FDA completed an inspection of McGuff Pharmaceuticals, Inc. on August 24, 2011 in Santa Ana, CA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
August 24, 2011
Fiscal Year
2011
Product Type
Drugs
Project Area
Unapproved and Misbranded Drugs
Location
Santa Ana, CA (United States)

Facility

Other inspections at this facility

  • 1268175 (OAI Mon Apr 28 2025 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1229677 (NAI Tue Aug 20 2024 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1110847 (VAI Fri Nov 22 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1083919 (VAI Tue Mar 26 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1013240 (NAI Fri Jun 02 2017 00:00:00 GMT+0000 (Coordinated Universal Time))

Recent compliance actions

FDA data resources